6 March 2024
At the meeting of 6 February 2024 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
seborrhoeic keratosis | 19/2024 | 20/2024 |
acute myeloid leukaemia | 21/2024 | 22/2024 |
osteomyelitis | 23/2024 | 24/2024 |
hallux valgus | 25/2024 | 26/2024 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined New Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
myocarditis | 17/2024 | 18/2024 |
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
malignant neoplasm of the lung | 27/2024 | |
soft tissue sarcoma | 27/2024 | |
Hodgkin lymphoma | 27/2024 | |
malignant neoplasm of the prostate | 27/2024 | |
malignant neoplasm of the larynx | 27/2024 | |
myeloma | 27/2024 | |
non-Hodgkin lymphoma | 27/2024 | |
depressive disorder | 28/2024 | |
cervical intervertebral disc prolapse | 29/2024 | 30/2024 |
Determined to revoke and not reissue Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
horseshoe kidney | 31/2015 | 32/2015 |
The above SOPs and Revocations take effect from 26 March 2024.
Finalised Declarations for:
Condition | Declaration | Reasons for Decision |
---|---|---|
new daily persistent headache | ||
horseshoe kidney |
Completed Investigations
The above determinations, declarations and revocations conclude the previously advertised investigations into:
The above declaration notices appear in the Government Notices Gazette of 28 February 2024.